CHEUNG KONG PROPERTY HOLDINGS LIMITED. (Incorporated in the Cayman Islands with limited liability) (Stock Code: 1113)

Similar documents
Members of The Chinese Medicine Council of Hong Kong, Chinese Medicine Practitioners Board, Chinese Medicines Board and its Committees

DISCLOSEABLE AND CONNECTED TRANSACTION AND PROPOSED APPOINTMENT OF CHIEF EXECUTIVE OFFICER

Name List of Scout of the Year

Name List of Scout of the Year

Appendix 5 Members of the Chinese Medicine Council of Hong. Kong, Chinese Medicine Practitioners Board, Chinese

AFFIN HOLDINGS BERHAD (Company No.: W) (Incorporated in Malaysia under the Companies Act, 2016) NOTICE TO SHAREHOLDERS IN RELATION TO THE

Advance Planning in Preparation of Potential Outbreak of Avian/Swine Flu for BRE

Advance Planning in Preparation of Potential Outbreak of Avian Flu for BRE

Kwun Tong Government Secondary School 34th Annual Swimming Gala ( ) Master Participant List for All Events. 25m FREE STYLE (Boy C)

RULES OF CONDUCT OF INSIDERS RESPECTING

President s Message. Professor Edward Chin Man LO. Spring Dear Fellows & Members,

BTM RESOURCES BERHAD

PRESENTATION ON 2017 THIRD QUARTERLY RESULTS

BVI Limited Partnership Hedge Funds: Calling Japan

Agenda of the 5 th Hong Kong International Oncology Symposium

HILLENBRAND INDUSTRIES INC

List of Licensed Centres - Treatment (as at 12 October 2018) (17 nos.) (Appendix I shows the treatment services provided by individual centres)

College Secretariat. Room 902 Hong Kong Academy of Medicine Jockey Club Building 99 Wong Chuk Hang Road, Aberdeen Hong Kong SAR

Recommended Ethical Principles. on Partner Counselling and Referral for. HIV Infected Individuals in Hong Kong

Annex 1. CHOONG YEE HOW List of past directorships. 1. Hong Leong Islamic Bank Berhad. 2. Promilia Berhad. 3. HL Asset Management Pte Ltd

Name of Person Responsible. MOK Ka-ming, Charles. Christine. Patrick. Dr. CHOW Mei Sin CHOW Mei Sin Room 1701, 238 Nathan Road, Kowloon.

Annual Statement of the Council The Federation of Medical Societies of Hong Kong 7th November 2001

Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company)

1965 Hughes Margaret The epistemological foundations of ethics with special reference to the views of Wang Yang-Ming and Immanuel Kant

List of Licensed Centres - Treatment (as at 12 March 2018) (17 nos.) (Appendix I shows the treatment services provided by individual centres)

College Secretariat. Room 902 Hong Kong Academy of Medicine Jockey Club Building 99 Wong Chuk Hang Road, Aberdeen Hong Kong SAR

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE

ACACIA PHARMA ANNOUNCES ITS INTENTION TO LAUNCH AN INITIAL GLOBAL OFFERING AND TO LIST ITS SHARES ON EURONEXT BRUSSELS

Competitive External Funds Obtained by FHSS Staff in (viz. July 2016 to June 2017)

Journal of Chinese Medicine. Vol.20, No.1, Vol.20, No.3,

Order form for Publications of Divinity School of Chung Chi College / Lecturers

The Dental Council of Hong Kong ANNUAL REPORT

SMARTPAY HOLDINGS LIMITED ANNUAL MEETING WEDNESDAY 26 SEPTEMBER 2017

Wings of Hope Gala Dinner Raising funds for HKBCF Jockey Club Breast Health Centre (Kowloon)

THE VILLAGE AT SAVANNAH QUARTERS

Pilot Study of Newborn Screening (NBS) for Inborn Errors of Metabolism (IEM) in Collaboration with Department of Health and Hospital Authority

Present : Prof John LEONG Chi-yan, SBS, JP (Chairman) Mr Ricky FUNG Choi-cheung, SBS, JP

Wai Mei WONG. Lydia Wai Yee CHAN. Billy Ming Hei LAI. Wai Yu WONG. Sin Man WONG. Ryan Chi Hang NUNG. Eric Ka Chai LAW

For personal use only

Hong Kong Thoracic Society. American College of Chest Physicians (HK & Macau Chapter) Hong Kong Lung Foundation

Investment in MGC Pharmaceuticals

MEMORANDUM OF UNDERSTANDING

Novo Nordisk has proposed to acquire Ablynx for up to per share in cash, consisting of upfront and 2.50 in Contingent Value Rights

Investor Presentation

11 January 2016, Monday, 1:30 pm to 5:30pm 1:30pm - 2:00pm Registration

Asset tracing in the British Virgin Islands

Brisa Concessão Rodoviária. 1Q 2017 Traffic Update

DW PENNICHUCK EAST UTILITY, INC. Petition for Franchise Approval and Rates. Order Nisi Approving Franchise and Rate Petition

PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public

Voting for the New President ( ) Nominees information

The Dental Council of Hong Kong. Annual Report

For personal use only

For personal use only

WALGREENS BOOTS ALLIANCE, INC.

COMMITTEE ON WORLD FOOD SECURITY

Report for the fourth quarter of 2016 and subsequent events (Un-audited)

HKSH 7 th Walk For A Vision HK$500,000 Donation Caring for Childhood Cancer Patients

CSA Briefing Note Regarding Joint Application against the University and Re-Commencing Collection of CFS/CFS-O Fees

Course Code. Course Unit. Term Offered. Research Paper Requirement. Instructors. Remarks

PROSPECTUS. Offer of up to 300,000 Convertible Resettable Preference Shares to raise up to $30,000,000. Whitefield Limited ABN

GENETIC TECHNOLOGIES LIMITED

Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement

REGIONAL SPECIALIZED GERIATRIC SERVICES GOVERNANCE AUTHORITY. Call for Expressions of Interest from Seniors Advocate/Public Member

Investor Relations 1Q 2017

News Release. - more - Hongkong Land Limited Incorporated in Bermuda with limited liability. Issued by:

Annual General Meeting 17 July 2018

SUMMARY TERM SHEET. Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL )

Analyst Report Written by Mark Bonacci, Chief Financial Analyst

List of Reports for Part II Professional Examination in Public Health Medicine written by successful candidates

Q4 Report Webcast February 7, 2019 Presenters: Renée Aguiar-Lucander, CEO Fredrik Johansson, CFO

All CRPS will have a maturity date of 18 months from the date of issuance of the first tranche of CRPS ( Maturity Date ).

These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017.

Tamsulosin Hydrochloride 0.4 mg Capsule

DARA Reports Year-End 2012 Financial Results

Chapter 9 Representational measurement and the presentation of accounting information in financial statements

Cochlear Limited 2018 Annual General Meeting

OWC Pharmaceutical Research Corp. (OTCQB: OWCP)

NOXOPHARM CORPORATE PRESENTATION FNN SHAW&PARTNERS INVESTOR EVENT ASX: NOX

MagSense Technology. For personal use only. Company Overview. A New Clinical Diagnostic Technology for Targeted Early Detection of Cancer

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

Better Patient Communication through Training Doctors and Healthcare Staff

Employment Contract. This sample employment contract is from Self-Employment vs. Employment Status, CDHA (no date available)

APPENDIX 4C SEPTEMBER 2018 QUARTER

OSA affects people of All Ages Delaying Diagnosis and Treatment causes Serious Complications. 17 th March, 2013 Press Conference

Department of Microbiology, The Chinese University of Hong Kong. Total CPD Credit Points. Objectives. Category. To give updated information

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

Change Announcement of Cessation::Retirement of Non Executive Chairman and Director. Issuer & Securities HONG LEONG ASIA LTD.

abcdefghijklmnopqrstu

Investor presentation. Bioshares Biotech Summit July 2017

Published by Student Affairs Office The Hong Kong Polytechnic University January 2013

College Secretariat. Room 902 Hong Kong Academy of Medicine Jockey Club Building 99 Wong Chuk Hang Road, Aberdeen Hong Kong SAR

Regional Osteoporosis Conference

Delivering high quality, cost effective cannabinoid medicines to patients (ASX:AC8) September 2018

FORM8-K HILLENBRAND,INC.

Hospital Authority Convention 2010 Presented by : Dr Cheng Ming Kin Medical Officer,Department of Medicine Tseung Kwan O Hospital

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

SPECIAL DISCLAIMER FOR INTERPRETING SERVICES INVOLVING CALLS TO EMERGENCY SERVICE PROVIDERS (911/E911), OR LEGAL, MEDICAL OR MENTAL HEALTH ISSUES

Any items to be debated or voted against must be removed from the Consent Agenda and considered separately.

A13. MISCELLANEOUS SERVICE ARRANGEMENTS

WORKSHOP: Physiotherapy for Parkinson's Disease

Transcription:

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. CHEUNG KONG PROPERTY HOLDINGS LIMITED (Incorporated in the Cayman Islands with limited liability) (Stock Code: 1113) THE EXTRAORDINARY GENERAL MEETING (Incorporated in Bermuda with limited liability) (Stock Code: 1038) THE SPECIAL GENERAL MEETING (Incorporated in Hong Kong with limited liability) (Stock Code: 6) THE GENERAL MEETING FORMATION OF A JOINT VENTURE IN CONNECTION WITH THE PROPOSED ACQUISITION OF ALL OF THE STAPLED SECURITIES IN ISSUE OF THE TARGET WHICH ARE LISTED ON THE AUSTRALIAN SECURITIES EXCHANGE BY WAY OF SCHEMES The CKPH Board announces that the Independent Shareholders Approval of CKPH has been obtained at the CKPH EGM. The CKI Board announces that the Independent Shareholders Approval of CKI has been obtained at the CKI SGM. The PAH Board announces that the Independent Shareholders Approval of PAH has been obtained at the PAH General Meeting. The CKPH Board, the CKI Board and the PAH Board jointly announce that as the Independent Shareholders Approvals of each of CKPH, CKI and PAH were obtained, the Joint Venture Transaction will proceed between CKPH, CKI and PAH on the basis that they will indirectly hold the Target as to 40%, 40% and 20%, respectively, subject to the Schemes becoming effective. As completion of the Acquisition depends on the fulfilment of certain conditions under the Scheme Implementation Agreement, there remains the possibility that the Acquisition may not proceed. Shareholders and potential investors should exercise caution when dealing in the shares of CKPH, CKI or PAH. 1

Reference is made to the joint announcement of CKPH, CKHH, CKI and PAH dated 16 January 2017 in relation to the Joint Venture Transaction and the Acquisition ( Announcement ). Unless otherwise defined, capitalised terms used in this announcement shall have the same meanings as those defined in the Announcement. THE EXTRAORDINARY GENERAL MEETING OF CKPH The CKPH Board announces that the poll results in respect of the resolution proposed at the extraordinary general meeting of CKPH held on 14 March 2017 ( CKPH EGM ) are as follows: RESOLUTION (Note 1) FOR To approve the connected transaction that is contemplated between CKPH and CKI pursuant to, or in connection with, the Consortium Formation Agreement including, but not limited to, the formation of a consortium between CKPH, CKI and (if applicable) PAH in relation to the Joint Venture Transaction. 1,457,266,311 (96.660437%) 50,347,726 (3.339563%) an ordinary resolution of CKPH. (1) For the full text of the resolution, please refer to the notice of the CKPH EGM dated 22 February 2017. As at the date of the CKPH EGM, the total number of CKPH shares in issue was 3,800,194,500 shares. As at the date of the CKPH EGM, each of Mr. Li Ka-shing, Mr. Li Tzar Kuoi, Victor and the relevant entities under the Trust (as defined in the circular of CKPH dated 22 February 2017) and their respective associates which together hold 1,164,801,060 CKPH shares representing approximately 30.65% of the total issued share capital of CKPH were required to abstain, and had so abstained, from voting on the resolution at the CKPH EGM. The total number of CKPH shares entitling the holders to attend and vote in respect of the resolution at the CKPH EGM was 2,635,393,440 shares. Save as disclosed above, no CKPH shareholder was required under the Listing Rules to abstain from voting on the resolution at the CKPH EGM. There were no CKPH shares entitling the holders thereof to attend and abstain from voting in favour of the resolution at the CKPH EGM pursuant to Rule 13.40 of the Listing Rules. Computershare Hong Kong Investor Services Limited, the Hong Kong Share Registrar of CKPH, acted as scrutineer for the poll at the CKPH EGM. 2

THE SPECIAL GENERAL MEETING OF CKI The CKI Board announces that the poll results in respect of the resolution proposed at the special general meeting of CKI held on 14 March 2017 ( CKI SGM ) are as follows: RESOLUTION (Note 2) FOR To approve the connected transaction that is contemplated between CKPH and CKI pursuant to, or in connection with, the Consortium Formation Agreement, including, but not limited to, the formation of a consortium between CKPH, CKI and (if applicable) PAH in relation to the Joint Venture Transaction. 338,084,998 (99.991127%) 30,002 (0.008873%) an ordinary resolution of CKI. (2) For the full text of the resolution, please refer to the notice of the CKI SGM dated 22 February 2017. As at the date of the CKI SGM, the total number of CKI shares in issue was 2,650,676,042 shares. As at the date of the CKI SGM, CKHH (through its wholly-owned subsidiaries), the relevant entities under the Trust (as defined in the circular of CKI dated 22 February 2017) and Mr. Li Tzar Kuoi, Victor s family member hold 1,906,681,945 shares, 5,428,000 shares and 227,000 shares in CKI, respectively (representing approximately 71.93%, 0.2% and 0.01% of the issued share capital of CKI, respectively). CKHH s subsidiaries, the relevant entities under the Trust (as defined in the circular of CKI dated 22 February 2017) and Mr. Li Tzar Kuoi, Victor and his associates abstained from voting on the resolution at the CKI SGM. As such, the total number of CKI shares entitling the holders to attend and vote in respect of the resolution at the CKI SGM was 738,339,097 shares. Save as disclosed above, no CKI shareholder was required under the Listing Rules to abstain from voting on the resolution at the CKI SGM. As stated in the announcement of CKI dated 23 February 2016, for so long as OVPH Limited ( OVPH ) holds the 131,065,097 CKI shares which CKI issued to OVPH on 2 March 2016, OVPH will not exercise the voting rights attached thereto. As such, at the CKI SGM, OVPH did not exercise the voting rights attached to 131,065,097 CKI shares it held as at the date of the CKI SGM. There were no CKI shares entitling the holders thereof to attend and abstain from voting in favour of the resolution at the CKI SGM pursuant to Rule 13.40 of the Listing Rules. Computershare Hong Kong Investor Services Limited, the branch share registrar of CKI, acted as scrutineer for the poll at the CKI SGM. 3

THE GENERAL MEETING OF PAH The PAH Board announces that the poll results in respect of the resolution proposed at the general meeting of PAH held on 14 March 2017 ( PAH General Meeting ) are as follows: RESOLUTION (Note 3) FOR To approve the connected transaction that is contemplated between CKPH (or, CKPH and CKI) on the one hand and PAH on the other hand pursuant to, or in connection with, the Consortium Formation Agreement, including, but not limited to, the formation of a consortium between CKPH, CKI (if applicable) and PAH in relation to the Joint Venture Transaction. 636,567,047 (99.792614%) 1,322,892 (0.207386%) an ordinary resolution of PAH. (3) For the full text of the resolution, please refer to the notice of the PAH General Meeting dated 22 February 2017. As at the date of the PAH General Meeting, the total number of PAH shares in issue was 2,134,261,654 shares. As at the date of PAH General Meeting, CKI and its associates which together hold 829,599,612 PAH shares representing approximately 38.87% of the total number of shares of PAH in issue were required to abstain, and had so abstained, from voting on the resolution at the PAH General Meeting. As such, the total number of PAH shares entitling the holders to attend and vote in respect of the resolution at the PAH General Meeting was 1,304,662,042 shares. Save as disclosed above, no PAH shareholder was required under the Listing Rules to abstain from voting on the resolution at the PAH General Meeting. There were no PAH shares entitling the holders thereof to attend and abstain from voting in favour of the resolution at the PAH General Meeting pursuant to Rule 13.40 of the Listing Rules. Computershare Hong Kong Investor Services Limited, the share registrar of PAH, acted as scrutineer for the poll at the PAH General Meeting. THE JOINT VENTURE TRANSACTION The CKPH Board, the CKI Board and the PAH Board jointly announce that as the Independent Shareholders Approvals of each of CKPH, CKI and PAH were obtained, the Joint Venture Transaction will proceed between CKPH, CKI and PAH on the basis that they will indirectly hold the Target as to 40%, 40% and 20%, respectively, subject to the Schemes becoming effective. 4

As completion of the Acquisition depends on the fulfilment of certain conditions under the Scheme Implementation Agreement, there remains the possibility that the Acquisition may not proceed. Shareholders and potential investors should exercise caution when dealing in the shares of CKPH, CKI or PAH. By order of the CKPH Board CHEUNG KONG PROPERTY HOLDINGS LIMITED Eirene Yeung By order of the CKI Board CHEUNG KONG INFRASTRUCTURE HOLDINGS LIMITED Eirene Yeung By order of the PAH Board POWER ASSETS HOLDINGS LIMITED Alex Ng Hong Kong, 14 March 2017 As at the date of this announcement, the CKPH Directors are Mr. LI Ka-shing (Chairman), Mr. LI Tzar Kuoi, Victor (Managing Director and Deputy Chairman), Mr. KAM Hing Lam (Deputy Managing Director), Mr. IP Tak Chuen, Edmond (Deputy Managing Director), Mr. CHUNG Sun Keung, Davy, Mr. CHIU Kwok Hung, Justin, Mr. CHOW Wai Kam, Ms. PAU Yee Wan, Ezra and Ms. WOO Chia Ching, Grace as Executive Directors; and Mr. CHEONG Ying Chew, Henry, Mr. CHOW Nin Mow, Albert, Ms. HUNG Siu-lin, Katherine, Mr. Simon MURRAY and Mr. YEH Yuan Chang, Anthony as Independent Non-executive Directors. As at the date of this announcement, the Executive Directors of CKI are Mr. LI Tzar Kuoi, Victor (Chairman), Mr. KAM Hing Lam (Group Managing Director), Mr. IP Tak Chuen, Edmond (Deputy Chairman), Mr. FOK Kin Ning, Canning (Deputy Chairman), Mr. Andrew John HUNTER (Deputy Managing Director), Mr. CHAN Loi Shun (Chief Financial Officer), Ms. CHEN Tsien Hua and Mr. Frank John SIXT; the Non-executive Directors are Mr. CHEONG Ying Chew, Henry (Independent Non-executive Director), Mrs. KWOK Eva Lee (Independent Non-executive Director), Mrs. SNG Sow-mei alias POON Sow Mei (Independent Non-executive Director), Mr. Colin Stevens RUSSEL (Independent Non-executive Director), Mr. LAN Hong Tsung, David (Independent Non-executive Director), Mr. Barrie COOK (Independent Non-executive Director), Mrs. LEE Pui Ling, Angelina and Mr. George Colin MAGNUS; and the Alternate Directors are Mrs. CHOW WOO Mo Fong, Susan (Alternate Director to Mr. FOK Kin Ning, Canning), Mr. MAN Ka Keung, Simon (Alternate Director to Mr. IP Tak Chuen, Edmond) and Ms. Eirene YEUNG (Alternate Director to Mr. KAM Hing Lam). As at the date of this announcement, the Executive Directors of PAH are Mr. FOK Kin Ning, Canning (Chairman), Mr. TSAI Chao Chung, Charles (Chief Executive Officer), Mr. CHAN Loi Shun, Mr. Andrew John HUNTER, Mr. Neil Douglas MCGEE and Mr. WAN Chi Tin; the Non-executive Director is Mr. LI Tzar Kuoi, Victor; and the Independent Non-executive Directors are Mr. IP Yuk-keung, Albert, Mr. Ralph Raymond SHEA, Mr. WONG Chung Hin and Mr. WU Ting Yuk, Anthony. 5